Digital health’s intersection of consumer technology, clinical science, and personalized medicine is creating one of the largest investment opportunities of our generation.
Market Transformation
The global digital health market is projected to reach $660 billion by 2025. Telemedicine, remote monitoring, AI diagnostics, and personalized nutrition platforms are all experiencing explosive growth.
Consumer Health Technology
Wearables, health tracking apps, direct-to-consumer lab testing, and personalized supplement programs are giving consumers unprecedented insight into and control over their health.
Portfolio Synergies
IKON Group’s healthcare portfolio — spanning clinical peptide therapy, nutraceuticals, and wellness retail — is well-positioned to integrate digital health capabilities that enhance outcomes and customer engagement.
Investment Criteria
We look for digital health companies with clinical validation, proven consumer engagement, strong unit economics, and potential to integrate with existing healthcare delivery systems.
About IKON Group Investments: IKON Group Investments is a Houston-based global holding company managing a diversified multi-billion dollar portfolio. For more market insights and investment perspectives, explore our Insights section.